Sorrento Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Sorrento Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q2 2023.
  • Sorrento Therapeutics, Inc. Operating Lease, Payments for the quarter ending June 30, 2023 was $4.09M, a 19.5% increase year-over-year.
  • Sorrento Therapeutics, Inc. Operating Lease, Payments for the twelve months ending June 30, 2023 was $15.6M, a 25.2% increase year-over-year.
  • Sorrento Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $13.6M, a 21.5% increase from 2021.
  • Sorrento Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $11.2M, a 13.6% increase from 2020.
  • Sorrento Therapeutics, Inc. annual Operating Lease, Payments for 2020 was $9.88M, a 42.5% increase from 2019.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $15.6M $4.09M +$667K +19.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $15M $4.23M +$1.33M +46.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $13.6M $3.71M +$744K +25.1% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 $12.9M $3.62M +$407K +12.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $12.5M $3.42M +$855K +33.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $11.6M $2.89M +$407K +16.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $11.2M $2.96M +$515K +21% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $10.7M $3.21M +$677K +26.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $10M $2.57M +$80K +3.22% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $9.95M $2.49M +$73K +3.02% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $9.88M $2.45M +$625K +34.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $9.26M $2.53M +$819K +47.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $8.44M $2.49M +$620K +33.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $7.82M $2.41M +$881K +57.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $6.94M $1.82M Oct 1, 2019 Dec 31, 2019 10-K 2021-02-19
Q3 2019 $1.71M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $1.87M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $1.53M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.